134 related articles for article (PubMed ID: 36004715)
1. Comparison of two probiotics in follow-on formula:
Dekker J; Quilter M; Qian H
Benef Microbes; 2022 Oct; 13(4):341-354. PubMed ID: 36004715
[TBL] [Abstract][Full Text] [Related]
2. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
Wickens K; Stanley TV; Mitchell EA; Barthow C; Fitzharris P; Purdie G; Siebers R; Black PN; Crane J
Clin Exp Allergy; 2013 Sep; 43(9):1048-57. PubMed ID: 23957340
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors.
Marlow G; Han DY; Wickens K; Stanley T; Crane J; Mitchell EA; Dekker J; Barthow C; Fitzharris P; Ferguson LR; Morgan AR
Pediatr Allergy Immunol; 2015 May; 26(3):262-271. PubMed ID: 25779902
[TBL] [Abstract][Full Text] [Related]
4. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.
Lai H; Li Y; He Y; Chen F; Mi B; Li J; Xie J; Ma G; Yang J; Xu K; Liao X; Yin Y; Liang J; Kong L; Wang X; Li Z; Shen Y; Dang S; Zhang L; Wu Q; Zeng L; Shi L; Zhang X; Tian T; Liu X
Gut Microbes; 2023; 15(1):2197837. PubMed ID: 37078654
[TBL] [Abstract][Full Text] [Related]
5. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years.
Wickens K; Barthow C; Mitchell EA; Kang J; van Zyl N; Purdie G; Stanley T; Fitzharris P; Murphy R; Crane J
Pediatr Allergy Immunol; 2018 Dec; 29(8):808-814. PubMed ID: 30430649
[TBL] [Abstract][Full Text] [Related]
6. Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT.
Murphy R; Morgan XC; Wang XY; Wickens K; Purdie G; Fitzharris P; Otal A; Lawley B; Stanley T; Barthow C; Crane J; Mitchell EA; Tannock GW
Benef Microbes; 2019 Feb; 10(1):5-17. PubMed ID: 30574802
[TBL] [Abstract][Full Text] [Related]
7. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Ibarra A; Latreille-Barbier M; Donazzolo Y; Pelletier X; Ouwehand AC
Gut Microbes; 2018; 9(3):236-251. PubMed ID: 29227175
[TBL] [Abstract][Full Text] [Related]
8. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial.
Wickens K; Black PN; Stanley TV; Mitchell E; Fitzharris P; Tannock GW; Purdie G; Crane J;
J Allergy Clin Immunol; 2008 Oct; 122(4):788-794. PubMed ID: 18762327
[TBL] [Abstract][Full Text] [Related]
9. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection.
Prescott SL; Wickens K; Westcott L; Jung W; Currie H; Black PN; Stanley TV; Mitchell EA; Fitzharris P; Siebers R; Wu L; Crane J;
Clin Exp Allergy; 2008 Oct; 38(10):1606-14. PubMed ID: 18631345
[TBL] [Abstract][Full Text] [Related]
10. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years.
Wickens K; Black P; Stanley TV; Mitchell E; Barthow C; Fitzharris P; Purdie G; Crane J
Clin Exp Allergy; 2012 Jul; 42(7):1071-9. PubMed ID: 22702506
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium animalis subsp. lactis fails to prevent common infections in hospitalized children: a randomized, double-blind, placebo-controlled study.
Hojsak I; Tokić Pivac V; Močić Pavić A; Pasini AM; Kolaček S
Am J Clin Nutr; 2015 Mar; 101(3):680-4. PubMed ID: 25733653
[TBL] [Abstract][Full Text] [Related]
12. Differential modification of genetic susceptibility to childhood eczema by two probiotics.
Morgan AR; Han DY; Wickens K; Barthow C; Mitchell EA; Stanley TV; Dekker J; Crane J; Ferguson LR
Clin Exp Allergy; 2014 Oct; 44(10):1255-65. PubMed ID: 25146491
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients.
Invernici MM; Furlaneto FAC; Salvador SL; Ouwehand AC; Salminen S; Mantziari A; Vinderola G; Ervolino E; Santana SI; Silva PHF; Messora MR
PLoS One; 2020; 15(9):e0238425. PubMed ID: 32960889
[TBL] [Abstract][Full Text] [Related]
14. Probiotic Bifidobacterium lactis Probio-M8 treated and prevented acute RTI, reduced antibiotic use and hospital stay in hospitalized young children: a randomized, double-blind, placebo-controlled study.
Mageswary MU; Ang XY; Lee BK; Chung YF; Azhar SNA; Hamid IJA; Bakar HA; Roslan NS; Liu X; Kang X; Dai L; Sreenivasan S; Taib F; Zhang H; Liong MT
Eur J Nutr; 2022 Apr; 61(3):1679-1691. PubMed ID: 34825264
[TBL] [Abstract][Full Text] [Related]
15. Effect of Probiotic Use on Antibiotic Administration Among Care Home Residents: A Randomized Clinical Trial.
Butler CC; Lau M; Gillespie D; Owen-Jones E; Lown M; Wootton M; Calder PC; Bayer AJ; Moore M; Little P; Davies J; Edwards A; Shepherd V; Hood K; Hobbs FDR; Davoudianfar M; Rutter H; Stanton H; Lowe R; Fuller R; Francis NA
JAMA; 2020 Jul; 324(1):47-56. PubMed ID: 32633801
[TBL] [Abstract][Full Text] [Related]
16. Use of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BB-12 and Enterococcus faecium L3 as prophylaxis to reduce the incidence of acute gastroenteritis and upper respiratory tract infections in children.
DI Pierro F; Lo Russo P; Danza ML; Basile I; Soardo S; Capocasale G; Paparone SB; Paletta V; Lanza C; Schiavone E; Risso P; Colombo M
Minerva Pediatr (Torino); 2021 Jun; 73(3):222-229. PubMed ID: 32506882
[TBL] [Abstract][Full Text] [Related]
17. Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study.
Rautava S; Salminen S; Isolauri E
Br J Nutr; 2009 Jun; 101(11):1722-6. PubMed ID: 18986600
[TBL] [Abstract][Full Text] [Related]
18. Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis.
Oliveira LF; Salvador SL; Silva PH; Furlaneto FA; Figueiredo L; Casarin R; Ervolino E; Palioto DB; Souza SL; Taba M; Novaes AB; Messora MR
J Periodontol; 2017 Feb; 88(2):197-208. PubMed ID: 27660886
[TBL] [Abstract][Full Text] [Related]
19. Impact of Bifidobacterium animalis subsp. lactis HN019 probiotic in the prevention of periodontitis associated with immunosuppression.
Maia LP; de Almeida Silva Levi YL; Henrique Félix Silva P; Carla Wons L; Pizzo Pitelli L; Goulart de Castro J; da Silva Dólens E; Gregorio D; Gouveia Straioto F; Dos Santos Santinoni C; Casarin R; Ervolino E; Aparecida Chaves Furlaneto F; Reis Messora M
J Periodontol; 2023 Mar; 94(3):389-404. PubMed ID: 36245273
[TBL] [Abstract][Full Text] [Related]
20. Effect of early probiotic supplementation on childhood cognition, behaviour and mood a randomised, placebo-controlled trial.
Slykerman RF; Kang J; Van Zyl N; Barthow C; Wickens K; Stanley T; Coomarasamy C; Purdie G; Murphy R; Crane J; Mitchell EA
Acta Paediatr; 2018 Dec; 107(12):2172-2178. PubMed ID: 30246890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
